|

Ivonescimab 10 mg/kg Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AK112, Akeso, SMT112

Pipeline

Phase 2: 1

Top Sponsors

  • PrECOG, LLC.1

Indications

  • Extensive Stage Lung Small Cell Cancer1
  • Lung Cancer1
  • Cancer1

Wausau, Wisconsin1 trial

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Aspirus Cancer Center Wausau

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.